Literature DB >> 7730454

Cocaine-exposed children: follow-up through 30 months.

H Hurt1, N L Brodsky, L Betancourt, L E Braitman, E Malmud, J Giannetta.   

Abstract

This prospective, blinded study evaluates the effect of in utero cocaine exposure on outcome of nonasphyxiated, term and near-term children born to women of low socioeconomic status. Two hundred nineteen children (101 cocaine-exposed and 118 control) with extensive natal evaluations are evaluated at 6-month intervals. We report here growth, performance on the Bayley Scales of Infant Development (BSID) through 30 months of age, and tone and reflexes at 6 and 12 months. To date, subjects have had 816 follow-up visits, with subject retention greater than or equal to 73%. Cocaine-exposed children showed statistically lower mean weights and smaller mean head circumferences than control children over the 30-month follow-up period (p < or = .011). The percentage of children with abnormal tone and reflexes, however, was similar in the two groups at 6 and 12 months (p > or = .34). Mean BSID Mental Development Index (MDI) and Psychomotor Development Index scores did not differ between the two groups (p > or = .16), although both groups' scores decreased over time (p < .001). Of concern, both cocaine-exposed and control groups had lower mean MDI scores than those published for a group of children of higher socioeconomic status. We conclude that, in our cohort of children, low socioeconomic or minority status may have had a substantial influence on BSID scores whereas in utero drug exposure did not.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730454

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  33 in total

1.  Norepinephrine transporter expression and function in noradrenergic cell differentiation.

Authors:  M Sieber-Blum; Z Ren
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome.

Authors:  L Singer; R Arendt; K Farkas; S Minnes; J Huang; T Yamashita
Journal:  Dev Psychopathol       Date:  1997

3.  Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children.

Authors:  Virginia A Rauh; Robin Garfinkel; Frederica P Perera; Howard F Andrews; Lori Hoepner; Dana B Barr; Ralph Whitehead; Deliang Tang; Robin W Whyatt
Journal:  Pediatrics       Date:  2006-11-20       Impact factor: 7.124

4.  Offspring from families at high risk for alcohol dependence: increased body mass index in association with prenatal exposure to cigarettes but not alcohol.

Authors:  Shirley Y Hill; Sa Shen; Jeannette Locke Wellman; Eric Rickin; Lisa Lowers
Journal:  Psychiatry Res       Date:  2005-06-30       Impact factor: 3.222

5.  Neurobehavioral and Developmental Traiectories Associated with Level of Prenatal Cocaine Exposure.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  J Neurol Psychol       Date:  2014-11

6.  Medical and Psychologic Risks of Maternal Cocaine Use.

Authors:  Lynn Singer; Robert E Arendt; Sonia Minnes; Rachel M Garber
Journal:  Resid Staff Physician       Date:  1997-10

Review 7.  Prenatal substance abuse: short- and long-term effects on the exposed fetus.

Authors:  Marylou Behnke; Vincent C Smith
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

Review 8.  Effect of socioeconomic status disparity on child language and neural outcome: how early is early?

Authors:  Hallam Hurt; Laura M Betancourt
Journal:  Pediatr Res       Date:  2015-10-20       Impact factor: 3.756

9.  Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2002-09

10.  Characteristics of pregnant substance abusers in two cities in the northeast.

Authors:  M Bendersky; S Alessandri; P Gilbert; M Lewis
Journal:  Am J Drug Alcohol Abuse       Date:  1996-08       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.